Scout | Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant

Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed)

The National Cancer Institute is offering grants for research involving bacteria, bacteriophages, or non-oncolytic viruses to study their interactions with tumors and the immune system. The aim is to explore their clinical potential for cancer imaging, therapeutics, or diagnostics. Projects may focus on using these microorganisms as anti-tumor agents, immunity activators, or delivery vehicles …

Source

Agency: National Institutes of Health

Sub-agency: National Cancer Institute

Dates

Opportunity Released: November 7, 2024

Keywords

cancer therapy

microbial-based therapy

tumor imaging

anti-tumor immunity

cancer diagnostics

bacteria and cancer

bacteriophages

non-oncolytic viruses

microbial tumor interactions

preclinical studies

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers